NU Skin Admitted Illegal Sales In China to U.S. SEC
This article was originally published in PharmAsia News
After exposure in the media, Nu Skin acknowledged that the company discovered illegal behavior by some dealers who did not comply with applicable regulations, and the company promised to correct the situation.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.